Opko Health made significant progress in its diagnostics and pharmaceutical segments. Key developments include advancing ModeX cancer programs, collaborative research with Merck, and progress in the development of the oxyntomodulin analogue.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing